|
|
|
               |
  membership | research programs | shared services | disease oriented working groups | related links | 2007 significant published accomplishments
The research accomplishments of our UWCCC members are numerous. Below highlights some of the significant published papers from 2007 organized by research program. Names in bold indicate UWCCC members. Cancer
Cell Biology Johnson KD, Boyer ME, Kang JA, Wickrema A, Cantor AB, Bresnick EH. Friend of GATA-1-independent transcriptional repression: a novel mode of GATA-1 function. Blood. 2007 Jun 15;109(12):5230-3. Epub 2007 Mar 5. Kim SI, Bultman SJ, Jing H, Blobel GA, Bresnick EH. Dissecting molecular steps in chromatin domain activation during hematopoietic differentiation. Mol Cell Biol. 2007 Jun;27(12):4551-65. Epub 2007 Apr 16. Wu J, Bresnick EH. Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation. Mol Cell Biol. 2007 Mar;27(6):2411-22. Epub 2007 Jan 12. Lugus JJ, Chung YS, Mills JC, Kim SI, Grass J, Kyba M, Doherty JM, Bresnick EH, Choi K. GATA2 functions at multiple steps in hemangioblast development and differentiation. Development. 2007 Jan;134(2):393-405. Epub 2006 Dec 13. Bruxvoort KJ, Charbonneau HM, Giambernardi TA, Goolsby JC, Qian CN, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis BD, Sigler RE, Resau JH, Sullivan R, Bushman W, Williams BO. Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res 67(6):2490-6, 2007 Mar 15. Johnson AR, Munoz A, Gottlieb JR, Jarrard DF. High-dose Zinc Increases Hospital Admissions Due to Genitourinary Complications. J Urol. 177(2):639-43, 2007 Best S, Sawers, Y, Fu V, Almassi N, Huang W, Jarrard DF. Integrity of Prostatic Tissue for Molecular Analysis After Robotic-Assisted Laparoscopic and Open Prostatectomy. Urology.2007 Aug 70 70 (2):328-32. Carlson CB, Mowery P, Owen RM, Dykhuizen EC, Kiessling LL. Selective tumor cell targeting using low-affinity, multivalent interactions. ACS Chem Biol. 2007 Feb 20;2(2):119-27. Epub 2007 Feb 26. Owen RM, Carlson CB, Xu J, Mowery P, Fasella E, Kiessling LL. Bifunctional ligands that target cells displaying the alpha v beta3 integrin. Chembiochem. 2007 Jan 2;8(1):68-82. van Ginkel PR, Sareen D, Subramanian L, Walker Q, Darjatmoko SR, Lindstrom MJ, Kulkarni A, Albert DM, Polans AS. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res. 2007 Sep 1;13(17):5162-9. Sareen D, Darjatmoko SR, Albert DM, Polans AS. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol. 2007 Dec;72(6):1466-75. Epub 2007 Sep 11. MacKenzie DA, Schartner J, Lin J, Timmel A, Jennens-Clough M, Fathman CG, Seroogy CM. GRAIL is Upregulated in CD4+CD25+ T Regulatory Cells and is Sufficient for Conversion of T Cells to a Regulatory Phenotype.J Biol Chem. 2007 Mar 30;282(13):9696-702. Epub 2007 Jan 26. Swartz TE, Tseng TS, Frederickson MA, Paris G, Comerci DJ, Rajashekara G, Kim JG, Mudgett MB, Splitter GA, Ugalde RA, Goldbaum FA, Briggs WR, Bogomolni RA. Blue-light-activated histidine kinases: two-component sensors in bacteria. Science. 2007 Aug 24;317(5841):1090-3. Higashimoto K, Kuhn P, Desai D, Cheng X, Xu W. Phosphorylation-mediated inactivation of coactivator-associated arginine methyltransferase 1. Proc Natl Acad Sci U S A 104(30):12318-23, 2007 Jul 24. Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM. Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat. 2007 Oct;105(2):195-207.Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet. 2007 May;121(3-4):483-90. Sprague BL, Trentham-Dietz A, Newcomb PA, Titus-Ernstoff L, Hampton JM, Egan KM. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):236-43. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer. 2007 Mar-Apr;17(2):441-6. Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis. 2007 Aug;28(8):1680-6. Liang X, Trentham-Dietz A, Titus-Ernstoff L, Newcomb PA , Welch RA, Hutchinson AA, Hampton JM, Sutcliffe CB, Haines JL, Egan KM. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1610-4. Trentham-Dietz A, Nichols HB, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Cigarette smoking and risk of breast carcinoma in situ. Epidemiology. 2007 Sep;18(5):629-38. Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Oral contraceptive use and risk of breast carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2262-8. McElroy JA, Shafer MM, Trentham-Dietz A, Hampton JM, Newcomb PA. Urinary cadmium levels and tobacco smoke exposure in women age 20-69 years in the United States. J Toxicol Environ Health A. 2007 Oct;70(20):1779-82. McElroy JA, Shafer MM, Hampton JM, Newcomb PA. Predictors of urinary cadmium levels in adult females. Sci Total Environ. 2007 Sep 1;382(2-3):214-23. Epub 2007 Jun 1. McElroy JA, Egan KM, Titus-Ernstoff L, Anderson HA, Trentham-Dietz A, Hampton JM, Newcomb PA. Occupational exposure to electromagnetic field and breast cancer risk in a large, population-based, case-control study in the United States. J Occup Environ Med. 2007 Mar;49(3):266-74. McElroy JA, Gangnon
RE, Newcomb PA, Kanarek MS, Anderson
HA, Brook JV, Trentham-Dietz
A, Remington PL.
Risk of breast cancer for women living in rural areas from adult exposure to
atrazine from well water in Wisconsin.
J Expo Sci Environ Epidemiol. 2007 Mar;17(2):207-14. Epub 2006 Jul 5. Samuelson DJ, Hesselson SE, Aperavich BA, Zan Y, Haag JD, Trentham-Dietz A, Hampton JM, Mau B, Chen KS, Baynes C, Khaw KT, Luben R, Perkins B, Shah M, Pharoah PD, Dunning AM, Easton DF, Ponder BA, Gould MN. Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6299-304. Epub 2007 Apr 2. Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res. 2007 Mar 1;13(5):1611-9. Albert DM, Scheef EA, Wang S, Mehraein F, Darjatmoko SR, Sorenson CM, Sheibani N. Calcitriol is a potent inhibitor of retinal neovascularization. Invest Ophthalmol Vis Sci. 2007;48:2327-2334. Parekh N, Chappell RJ, Millen AE, Albert DM, Mares JA. Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey 1988 through 94. Arch Ophthalmol. 2007;125:661-669. van Ginkel PR, Sareen D, Subramanian L, Takach JC, Walker Q, Darjatmoko SR, Lindstrom M, Kulkarni AD, Albert DM, Polans AS. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res. 2007;13:5162-5169. van Ginkel PR, Yang W, Marcet MM, Chow CC, Kulkarni AD, Darjatmoko S, Lindstrom MJ, Lokken J, Bhattacharya S, Albert DM. . 1α-hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol. 2007;85:255-262. Sareen D, Darjatmoko SR, Albert DM, Polans AS. Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol. 2007;72:1466-1475. Kolesar JM, Schelman WR, Geiger PG, Holen KD, Traynor AM, Alberti DB, Thomas JP, Chitambar CR, Wilding G, Antholine WE. Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine((R)). J Inorg Biochem 2007 Oct 30. Dubovsky JA, McNeel DG. Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor. Prostate. 2007 Dec 1;67(16):1781-90. Olson BM, McNeel DG. Antibody and T-cell responses specific for the androgen receptor in patients with prostate cancer. Prostate. 2007 Dec 1;67(16):1729-39. Dubovsky JA, Albertini MR, McNeel DG. MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis. J Immunother. 2007 Oct;30(7):675-83. Johnson LE, Frye TP, Chinnasamy N, Chinnasamy D, McNeel DG. Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells. Cancer Immunol Immunother. 2007 Jun;56(6):885-95. Epub 2006 Nov 11. Robins HI, O'neill A, Gilbert M, Olsen M, Sapiente R, Berkey B, Mehta M. Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial. Cancer Chemother Pharmacol. 2007 Sep 20 [Epub ahead of print]. Kennedy DR, Gawron LS, Ju J, Liu W, Shen B, Beerman TA. Single chemical modifications of the C-1027 enediyne core, a radiomimetic antitumor drug, affect both drug potency and the role of ataxia-telangiectasia mutated in cellular responses to DNA double-strand breaks. Cancer Res 67(2):773-81, 2007 Jan 15. Imaging and Radiation Sciences Huang B, Chappell R. Three-dose-cohort designs in cancer phase I trials. Stat Med. 2007 Aug 31; [Epub ahead of print] Gutiérrez AN, DeVeau M, Forrest LJ, Tomé WA, Mackie TR. Radiobiological and Treatment Planning Study of a Simultaneous-Integrated Boost for Canine Nasal Tumors using Helical Tomotherapy. Vet Radiol Ultrasound. 2007, 48(6):594-602. Lazebnik M, Popovic D, McCartney L, Watkins CB, Lindstrom MJ, Harter J, Sewall S, Ogilvie T, Magliocco A, Breslin TM, Temple W, Mew D, Booske JH, Okoniewski M, Hagness SC. A large-scale study of the ultrawideband microwave dielectric properties of normal, benign and malignant breast tissues obtained from cancer surgeries. Phys Med Biol. 2007 Oct 21;52(20):6093-115. Epub 2007 Oct 1. Lazebnik M, McCartney L, Popovic D, Watkins CB, Lindstrom MJ, Harter J, Sewall S, Magliocco A, Booske JH, Okoniewski M, Hagness SC. A large-scale study of the ultrawideband microwave dielectric properties of normal breast tissue obtained from reduction surgeries. Phys Med Biol. 2007 May 21;52(10):2637-56. Epub 2007 Apr 23. Schwechter BR, Millet LE, Levin LA. Histone deacetylase inhibition-mediated differentiation of RGC-5 cells and interaction with survival. Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2845-57. Levin LA, Palmer JG. Institutional review boards should require clinical trial registration. Arch Intern Med. 2007 Aug 13-27;167(15):1576-80. Lieven CJ, Millet LE, Hoegger MJ, Levin LA. Induction of axon and dendrite formation during early RGC-5 cell differentiation. Exp Eye Res. 2007 Nov;85(5):678-83. Epub 2007 Aug 8.
|
|||||
|
|
|
|
